CGP-35348
| CGP-35348 | |
|---|---|
| CGP-35348 structure.png | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | 5311055 |
| DrugBank | |
| ChemSpider | 4470910 |
| KEGG | D03457 |
CGP-35348 is a compound that acts as a GABA B receptor antagonist. It is used in scientific research to investigate the role of GABA B receptors in various physiological and neurological processes.
Mechanism of Action[edit]
CGP-35348 works by inhibiting the action of gamma-Aminobutyric acid (GABA) at the GABA B receptor. This receptor is a G-protein coupled receptor that mediates slow and prolonged inhibitory signals in the central nervous system. By blocking this receptor, CGP-35348 can modulate neurotransmission and affect various neurological and psychiatric conditions.
Research Applications[edit]
CGP-35348 has been used in various preclinical studies to understand the role of GABA B receptors in anxiety, depression, epilepsy, and pain. It has also been investigated for its potential effects on cognition and memory.
Pharmacokinetics[edit]
The pharmacokinetics of CGP-35348 involve its absorption, distribution, metabolism, and excretion. Detailed studies on its bioavailability, half-life, and metabolic pathways are essential for understanding its potential therapeutic applications.
Safety and Toxicology[edit]
As with any pharmacological agent, the safety and toxicology profile of CGP-35348 is crucial. Studies typically focus on its LD50, potential side effects, and long-term impact on organ systems.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
